Igor Feldman

2.4k citations

24 papers · 1.2k indexed · h-index 9

Computational Theory and Mathematics top 2%
Molecular Biology top 10%
- Epigenetics and DNA Methylation 6
- PI3K/AKT/mTOR signaling in cancer 4
- Protein Degradation and Inhibitors 3
- DNA Repair Mechanisms 2
Oncology top 10%
- Cancer Immunotherapy and Biomarkers 3
Cancer Research
- Cancer, Hypoxia, and Metabolism 3
Pathology and Forensic Medicine top 10%
Immunology
- Immune cells in cancer 8
- Phagocytosis and Immune Regulation 5

Co-authors: Andrey Rzhetsky Dennis Vitkup Brian S. Roberts Yair Benita Yaping Liu Stuart D. Shumway Theresa Zhang William T. Arthur
Cited by: Computational Theory and Mathematics Molecular Biology Oncology
Journals: Molecular Cancer Therapeutics (5 papers)Cancer Research (5 papers)Journal of Clinical Oncology (2 papers)
Partner nations: United States Australia Ireland

In The Last Decade

Igor Feldman

24 papers receiving 1.1k citations

Peers

Countries citing papers authored by Igor Feldman

Since Specialization

Citations

This map shows the geographic impact of Igor Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Feldman more than expected).

Fields of papers citing papers by Igor Feldman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Feldman. The network helps show where Igor Feldman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Igor Feldman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Igor Feldman Line = papers co-authored together Igor Feldman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abstract 855: Dynamics of T cell and T cell receptor following mRNA-4157 (V940) plus pembrolizumab or pembrolizumab alone in resected melanoma from the mRNA-4157-P201 (KEYNOTE-942) trial Cancer Research ·S. Morell-Dubois,Ryan J. Sullivan,Jacky Chow,Janice M. Mehnert,Matteo S. Carlino,Adnan Khattak,George Ansstas,Matthew H. Taylor,Meredith McKean,Georgina V. Long,Mark B. Faries,Jason J. Luke,Rovshan Amiraliyev,Laureen S. Ojalvo,Filippos Porichis,Igor Feldman,Lakshmi Srinivasan	2025	1
2	Antibodies Targeting Human or Mouse VSIG4 Repolarize Tumor-Associated Macrophages Providing the Potential of Potent and Specific Clinical Anti-Tumor Response Induced across Multiple Cancer Types International Journal of Molecular Sciences ·Stephen L. Sazinsky,Mohammad Zafari,Boris Klebanov,Dasari Srinu,J.M. Thomson,Ryan Phennicie,Norma K. Raffel,Kevin Kauffman,Albert Gyorgy Borbely,Denise Manfra,Igor Feldman,Tatiana I. Novobrantseva	2024	4
3	Abstract CT141: mRNA-4157 (V940) individualized neoantigen therapy (INT) + pembrolizumab (pembro) in advanced unresectable HPV- head & neck carcinoma (HNSCC): Clinical & translational analysis Cancer Research ·Julie E. Bauman,Ricklie Julian,J.L. Geiger,Janice M. Mehnert,Jeffrey Clarke,Manish R. Patel,Martin Gutierrez,Justin F. Gainor,Shyam Srivats,François Pourny,Rovshan Amiraliyev,Vasudha Sehgal,Peijie Hou,مصطفی کمالجو,Igor Feldman,Lakshmi Srinivasan,Praveen Aanur,Michelle Brown,Robert Meehan	2024	3
4	PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages Cancer Research Communications ·Kevin Kauffman,Denise Manfra,Erin Oakley,Mohammad Zafari,J.M. Thomson,Ryan Phennicie,Elisabeth H. Vollmann,V. O. Nagibina,立夫万,M. Slezáková,Jeanne Graziano,Elizabeth K. Culyba,Joseph Wahle,Carola H. Ries,Michael A. Brehm,Dolores Paulina Ramírez Flores,Igor Feldman,Tatiana I. Novobrantseva	2023	8
5	Minimal residual disease by circulating tumor DNA as a biomarker of recurrence free survival in resected high-risk melanoma patients treated with mRNA-4157/V940, a personalized cancer vaccine, and pembrolizumab. Journal of Clinical Oncology ·Matteo S. Carlino,Adnan Khattak,Jeffrey S. Weber,Tarek Meniawy,Ryan J. Sullivan,Matthew H. Taylor,Kevin B. Kim,Meredith McKean,Mark B. Faries,C. Lance Cowey,Geoffrey T. Gibney,Jason J. Luke,Sajeve Thomas,Vasudha Sehgal,Igor Feldman,Praveen Aanur,Michelle Brown,Robert Meehan,Céline Robert-Tissot,Georgina V. Long	2023	4
6	Abstract 5613: Targeting VSIG4, a novel macrophage checkpoint, repolarizes suppressive macrophages which induces an inflammatory response in primary cell in vitro assays and fresh human tumor cultures, and inhibits tumor growth in in vivo murine tumor models Cancer Research ·Stephen L. Sazinsky,雅博大内,Mohammad Zafari,Boris Klebanov,Dasari Srinu,M. Slezáková,Denise Manfra,Igor Feldman,Tatiana I. Novobrantseva	2022	1
7	Abstract P105: Targeting VSIG4, a novel macrophage checkpoint, repolarizes suppressive macrophages which induces an inflammatory response in primary cell in vitro assays and fresh human tumor cultures Molecular Cancer Therapeutics ·志津小野寺,雅博大内,Mohammad Zafari,Ryan Phennicie,Norma K. Raffel,M. Slezáková,Agustí Barceló Cortés,Tomoki Uchimura,Boris Klebanov,Dasari Srinu,Denise Manfra,Igor Feldman,Tatiana I. Novobrantseva	2021	3
8	877 PSGL-1 blocking antibodies repolarize tumor associated macrophages, reduce suppressive myeloid populations and induce inflammation in the tumor microenvironment, leading to suppression of tumor growth Regular and Young Investigator Award Abstracts ·Phuong Nguyen,Dasari Srinu,Mohammad Zafari,Denise Manfra,M. Slezáková,V. O. Nagibina,Ryan Phennicie,Kevin Kauffman,Erin Oakley,Norma K. Raffel,志津小野寺,Michael A. Brehm,Igor Feldman,Tatiana I. Novobrantseva	2021	1
9	886 Targeting VSIG4, a novel macrophage checkpoint, repolarizes suppressive macrophages which induces an inflammatory response in primary cell in vitro assays and fresh human tumor cultures SHILAP Revista de lepidopterología ·志津小野寺,Phuong Nguyen,Mohammad Zafari,Ryan Phennicie,Norma K. Raffel,M. Slezáková,Agustí Barceló Cortés,Tomoki Uchimura,Boris Klebanov,Denise Manfra,Dasari Srinu,Igor Feldman,Tatiana I. Novobrantseva	2021	2
10	PSGL-1 is a novel macrophage checkpoint in immuno-oncology. Journal of Clinical Oncology ·Erin Oakley,Ryan Phennicie,Kevin Kauffman,Mohammad Zafari,Agustí Barceló Cortés,V. O. Nagibina,志津小野寺,Norma K. Raffel,Igor Feldman,Tatiana I. Novobrantseva	2020	2
11	EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCL Molecular Cancer Therapeutics ·Dormer Bj,Alexander Fåll,Allison E. Drew,Trupti Lingaraj,日本棋院東京本院,Natalie M. Warholic,Igor Feldman,Christopher Plescia,J. Joshua Smith,Robert A. Copeland,Heike Keilhack,Elayne Chan-Penebre,Sarah K. Knutson,Scott Ribich,Alejandra Raimondi,Michael J. Thomenius	2017	52
12	Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models Molecular Cancer Therapeutics ·Elayne Chan-Penebre,Kelli Armstrong,Allison E. Drew,Alexandra Grassian,Igor Feldman,Sarah K. Knutson,Kristy Kuplast‐Barr,Maria Roche,John Campbell,Peter Ho,Robert A. Copeland,Richard Chesworth,J. Joshua Smith,Heike Keilhack,Scott Ribich	2017	127
13	An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies Molecular Cancer Therapeutics ·Jennifer O’Neil,Yair Benita,Igor Feldman,Mélissa Chénard,Brian S. Roberts,Yaping Liu,Jing Li,Astrid M. Kral,Serguei Lejnine,Andrey Loboda,William T. Arthur,Răzvan Cristescu,Brian B. Haines,Christopher Winter,Theresa Zhang,Andrew Bloecher,Stuart D. Shumway	2016	227
14	Preclinical Evaluation of the WEE1 Inhibitor MK-1775 as Single-Agent Anticancer Therapy Molecular Cancer Therapeutics ·Amy D. Guertin,Jing Li,Yaping Liu,Melissa S. Hurd,Alwin G. Schuller,Brian J. Long,Heather A. Hirsch,Igor Feldman,Yair Benita,Carlo Toniatti,Leigh Zawel,Stephen E. Fawell,D. Gary Gilliland,Stuart D. Shumway	2013	143
15	Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibition Cancer Cell International ·Amy D. Guertin,Melissa M. Martin,Brian S. Roberts,Melissa S. Hurd,Xianlu Qu,Nathan R. Miselis,Yaping Liu,Jing Li,Igor Feldman,Yair Benita,Andrew Bloecher,Carlo Toniatti,Stuart D. Shumway	2012	65
16	Abstract 4931: Biomarker discovery in a large panel of cell lines shows different sample size requirement for prediction of response across a set of compounds Cancer Research ·Michael Nebozhyn,Răzvan Cristescu,Yaping Liu,Igor Feldman,Ken Westerheide,Theresa Zhang,Leigh Zawel,Stephen E. Fawell,Hongyue Dai,Jing Li,Andrey Loboda	2012	5
17	Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors Science Translational Medicine ·Jannik N. Andersen,Sriram Sathyanarayanan,Alessandra Di Bacco,An Chi,Theresa Zhang,Yanmei Dong,Brian Dolinski,Manfred Kraus,Brian S. Roberts,William T. Arthur,Тютюнник Алексей Вячеславович,Lettie Makola,Lixia Li,Igor Feldman,إبراهيم عبد الوهاب الطيار,A. John Rush,Ronald C. Hendrickson,Peter Blume‐Jensen,Cloud P. Paweletz	2010	134
18	A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors BMC Medical Genomics ·Andrey Loboda,Michael Nebozhyn,Тютюнник Алексей Вячеславович,Jason P. Frazier,Michael Chastain,William T. Arthur,Brian S. Roberts,Theresa Zhang,Mélissa Chénard,Brian B. Haines,Jannik N. Andersen,Kumiko Nagashima,Cloud P. Paweletz,إبراهيم عبد الوهاب الطيار,Igor Feldman,Hongyue Dai,Pearl S. Huang,James Watters	2010	107
19	Network properties of genes harboring inherited disease mutations Proceedings of the National Academy of Sciences ·Igor Feldman,Andrey Rzhetsky,Dennis Vitkup	2008	216
20	Bioinformatic analysis of autism positional candidate genes using biological databases and computational gene network prediction Genes Brain & Behavior ·Amanda L. Yonan,Abraham A. Palmer,Kenneth Smith,Igor Feldman,Suvi Varshney,たけじむの,S G Fischer,Paul Pavlidis,T. Conrad Gilliam	2003	50

About Igor Feldman

Igor Feldman is a scholar working on Immunology, Cancer Research and Molecular Biology, having authored 24 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immune cells in cancer (8 papers), Epigenetics and DNA Methylation (6 papers), Phagocytosis and Immune Regulation (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Protein Degradation and Inhibitors (3 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Computational Theory and Mathematics (248 citations), Molecular Biology (910 citations) and Oncology (261 citations). Igor Feldman has collaborated with scholars based in United States, Australia and Ireland. Frequent co-authors include Andrey Rzhetsky, Dennis Vitkup, Brian S. Roberts, Yair Benita, Yaping Liu, Stuart D. Shumway, Theresa Zhang, William T. Arthur, Andrey Loboda and Brian B. Haines. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Research, Journal of Clinical Oncology, Science Translational Medicine and Genes Brain & Behavior.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact